Search

Your search keyword '"Simard, Jacques"' showing total 1,969 results

Search Constraints

Start Over You searched for: Author "Simard, Jacques" Remove constraint Author: "Simard, Jacques"
1,969 results on '"Simard, Jacques"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

2. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

3. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

4. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

5. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

7. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

8. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

9. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

10. Personalized early detection and prevention of breast cancer: ENVISION consensus statement

11. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

12. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

13. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

14. A response to "Personalised medicine and population health: breast and ovarian cancer".

15. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

16. Rare germline copy number variants (CNVs) and breast cancer risk

18. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

19. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

20. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

21. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

22. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

24. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry

25. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

26. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.

27. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

28. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

29. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

30. RAD51B in Familial Breast Cancer.

32. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

33. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation

34. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

35. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

36. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

38. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

39. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

40. Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

41. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

42. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

43. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

44. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

45. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

46. Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

47. Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

48. Data from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

49. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Catalog

Books, media, physical & digital resources